Drew Austin welcomes two experts in the Biotech field to discuss discoveries in psychedelics, cancer treatment, and more. Peter Weijmarshausen, CEO/Co-founder of Humane Genomics and Sam Clark, Founder/CEO of Terran Biosciences highlight how biotech is offering amazing opportunities for investments in scientific innovation.

Participating Panelists:

- Drew Austin, Managing Partner, Red Beard Ventures

- Peter Weijmarshausen, CEO/Co-founder, Humane Genomics

- Sam Clark, Founder/CEO, Terran Biosciences

Main Topics:

- Terran Bioscience developing prescription psychedelic therapies for mental health.

- Human Genomics' revolutionary approach to using synthetic biology to target and eliminate cancer cells.

- The challenges of scientific innovation.

- Finding opportunities for capital deployment in biotech

- Developing affordable treatments for all - making healthcare accessible

Red Beard Ventures: https://redbeard.ventures/

Angel List Syndicate: https://venture.angellist.com/red-beard-ventures-drew-austin/syndicate?utm_campaign=syndicate_direct_link

Red Beard Radio is Sponsored by Alto. Alto makes it easy for individuals to invest in alternative assets with their retirement funds through a self-directed IRA. Access private deals on Alto Marketplace, their new platform for accredited investors: https://www.altoira.com/marketplace

X: @RedBeardVC

Watch the show on YouTube: https://www.youtube.com/channel/UCY-DGmpg2v2rEcXEjn8hJlw